Dynatrace target price cut to $65 from $70 by Rosenblatt Securities
DT•Rosenblatt Securities cut its target price for Dynatrace to $65 from $70.
Related News
Harmony Biosciences names Peter Anastasiou president and CEO effective Jan. 1, 2027
HRMY•
Eagle Nuclear Energy signs binding LOI to acquire Noble Plains Uranium
NUCL•
Booking Holdings target price cut to $210 from $247 by Wedbush
BKNG•
Arrowhead Pharmaceuticals prepays $400 million credit facility at $68 million discount
ARWR•
Criteo presents factsheet highlighting $4.6 billion in annual media spend
CRTO•